SIGA Technologies Inc announces new Request for Proposal for 1.7m courses of smallpox antiviral.
M2 EQUITYBITES-February 22, 2011-SIGA Technologies Inc announces new Request for Proposal for 1.7m courses of smallpox antiviral(C)2011 M2 COMMUNICATIONS http://www.m2.com
Pharmaceutical agents supplier SIGA Technologies Inc (Nasdaq:SIGA) said on Monday that it has received a new Request for Proposal, number 11-100 -SOL-00007, seeking to procure 1.7m courses of a smallpox antiviral.
This Request for Proposal has been committed by the Biomedical Advanced Research and Development Authority (BARDA), a unit of the US Department of Health and Human Services.
The company added the Request for Proposal also covers an option to procure up to 12m additional courses as part of the proposed deal.
In addition, the company said it plans to respond to BARDA'S new Request for Proposal on 28 February 2011.
((Comments on this story may be sent to email@example.com)).END.PUB430>PDFebruary 22, 2011>JNM2 EQUITYBITES.PRICEDATENOT APPLICABLE.DAY
|Printer friendly Cite/link Email Feedback|
|Publication:||M2 EquityBites (EQB)|
|Date:||Feb 22, 2011|
|Previous Article:||Chesapeake Energy Corporation disposes USD4.75bn Fayetteville Shale assets.|
|Next Article:||Westlake Chemical Corp board reports dividend payout of USD0.0635 per share.|